| Primary information |
|---|
| ID | 1041 |
| Peptide Name | Trauma induced immunosuppressive glycopeptide (TP) |
| Sequence | not available |
| Length | 0 |
| Chirality | NA |
| N-terminal Modification | NA |
| C-terminal Modification | NA |
| Chemical Modification | NA |
| Linear/ Cyclic | NA |
| Nature | Natural |
| Source of Origin | From arterial blood of burn or trauma patient |
| Target | neutrophils, T and B Lymphocytes |
| Mechanism of Action | Through stimulation of PGE2 biosynthesis and through a non-cyclooxygenasepathway. |
| In vitro/In vivo | In vitro |
| Cell Line | Mitomycin-treated stimulator Lymphocytes |
| Inhibition Concentartion | NA |
| In vivo Model | NA |
| Assay | Mixed Lymphocyte culture assay and TP-induced PGE2 biosynthesis assay |
| Lethal Dose | NA |
| Combination Therapy | NA |
| Pubmed ID | 2965105 |
| Year of Publication | 1988 |
| 3-D Structure | NA |
